AdamsonA. R., Grahame-SmithD. G., PeartW. S., StarrM. (1969). Pharmacological blockade of carcinoid flushing provoked by catecholamines and alcohol. Lancet, 2, 293
2.
AbeK., WatanabeN., KamagarN., MouriT., SekiT., YoshinagaK. (1967). Circulating kinin in patients with bronchial asthma. Experientia, 23, 626
3.
BiorckG., AxenO., ThrosonA. (1952). Unusual cyanosis in a boy with congenital pulmonary stenosis and tricuspid insufficiency. American Heart Journal, 44, 143
4.
CampbellA. C. P., GowenlockA. H., PlattD. S., SnowP. J. D. (1963). A 5-hydroxytryptophan secreting carcinoid tumoir. Gut, 4, 61
5.
ColebatchH. J. H., OlsenC. R., NadelJ. A. (1966). Effect of histamine serotonin and acetylcholine on the peripheral airways. Journal of Applied Physiology, 21, 217
6.
CostelloC. (1965). Management of the carcinoid syndrome. Archives of Surgery, 90, 787
7.
EngelmanK., LovenbergW., SjoerdsmaA. (1967). Inhibition of serotonin synthesis by parachlorophenylalanine in patients with carcinoid syndrome. New England Journal of Medicine, 277, 1103
8.
Grahame-SmithD. G. (1968). The carcinoid syndrome. American Journal of Cardiology, 21, 376
9.
HerxheimerH. (1953). Further observation on the influence of 5-hydroxytryptamine on bronchial function. Journal of Physiology, 122, 49P
10.
KabakowB., WeinsteinJ. B., RossG. (1958). Effects of iproniazid upon serotonin metabolism. Federation Proceedings, 17, 382
11.
KinlochJ. D., WebbJ. N., EcclestonD., ZeitlinI. J. (1965). Carcinoid syndrome associated with oat-cell carcinoma of bronchus. British Medical Journal, 1, 1533
12.
MashfordM. L., ZacestR. (1967). Effect of adrenaline on blood kinin levels in carcinoid syndrome and in normal subjects. Australasian Annals of Medicine, 16, 326
13.
MelmonK. L. (1968). Kinins—one of many mediators of the carcinoid spectrum. Gastroenterology, 55, 545
14.
MengelC. E. (1965). Therapy of the malignant carcinoid syndrome. Annals of Internal Medicine, 62, 587
15.
MichelsonA. L., HollanderW., LowellF. C. (1958). The effect of 5-hydroxytryptamine (serotonin) on the respiration of non-asthmatic subjects. Journal of Laboratory and Clinical Medicine, 51, 57
16.
Murray-LyonI. M., ParsonsV. A., BlendisL. M., DawsonJ. L., RakeM. O., LawsJ. W., WilliamsR. (1970). Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs. Lancet, 2, 172
17.
OatesJ. A., MelmonK. L., SjoerdsmaA., GillespieL., MasonD. T. (1964). Release of a kinin peptide in the carcinoid syndrome. Lancet, 1, 514
18.
OatesJ. A., PettingerW. A., DoctorR. B. (1966). Evidence for the release of bradykinin in carcinoid syndrome. Journal of Clinical Investigation, 45, 173
19.
OatesJ. A., SjoerdsmaA. (1962). A unique syndrome associated with secretion of 5-hydroxytryptophan by metastatic gastric carcinoids. American Journal of Medicine, 32, 333
20.
PeartW. S., RobertsonJ. I. S. (1961). The effect of a serotonin antagonist (UML 491) in carcinoid disease. Lancet, 2, 1172
21.
PeartW. S., RobertsonJ. I. S., AndrewsT. M. (1959). Facial flushing produced in patients with the carcinoid syndrome by intravenous adrenaline and noradrenaline. Lancet, 2, 715
22.
RobertsonJ. I. S., PeartW. S., AndrewsT. M. (1962). The mechanism of facial flushes in the carcinoid syndrome. Quarterly Journal of Medicine, 21, 103
23.
Rocha e SilvaM., LemeJ. G. (1963). Antagonists of bradykinin. Medicina Experimentalis, 8, 287
24.
SandierM., KarimS. M. M., WilliamsE. D. (1968). Prostaglandins in aminepeptide-secreting tumours. Lancet, 2, 1053
25.
SayleB. A., LangP. A., GreenW. O., BosworthW. C., GregoryR. (1965). Cushing's syndrome due to islet cell carcinoma of the pancreas. Annals of Internal Medicine, 63, 58
26.
ZeitlinI. J., SmithA. N. (1966). 5-Hydroxyindoles and kinins in the carcinoid and dumping syndromes. Lancet, 2, 986
